TREACE MEDICAL CONCEPTS, INC. Quarterly Selling and Marketing Expense in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Treace Medical Concepts, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q1 2020 to Q2 2024.
  • Treace Medical Concepts, Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $37.7M, a 11.6% increase year-over-year.
  • Treace Medical Concepts, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $151M, a 23.1% increase year-over-year.
  • Treace Medical Concepts, Inc. annual Selling and Marketing Expense for 2023 was $141M, a 34.7% increase from 2022.
  • Treace Medical Concepts, Inc. annual Selling and Marketing Expense for 2022 was $105M, a 59.9% increase from 2021.
  • Treace Medical Concepts, Inc. annual Selling and Marketing Expense for 2021 was $65.4M, a 107% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $151M $37.7M +$3.91M +11.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $148M $40.3M +$6.67M +19.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $141M $39.9M +$9.83M +32.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $131M $33.5M +$7.97M +31.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $123M $33.8M +$7.16M +26.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $116M $33.7M +$11.4M +50.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $105M $30.1M +$6.83M +29.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $97.7M $25.6M +$9.58M +60% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $88.2M $26.6M +$12.6M +89.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $75.6M $22.3M +$10.2M +83.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $65.4M $23.3M +$11.8M +104% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $53.6M $16M +$7.88M +97.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $45.7M $14M +$9.22M +193% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $36.5M $12.1M +$4.81M +65.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $31.7M $11.4M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-08
Q3 2020 $8.1M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $4.79M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $7.34M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.